Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;2(5):120082.
doi: 10.1098/rsob.120082.

Regulation of the transforming growth factor β pathway by reversible ubiquitylation

Affiliations
Review

Regulation of the transforming growth factor β pathway by reversible ubiquitylation

Mazin A Al-Salihi et al. Open Biol. 2012 May.

Abstract

The transforming growth factor β (TGFβ) signalling pathway plays a central role during embryonic development and in adult tissue homeostasis. It regulates gene transcription through a signalling cascade from cell surface receptors to intracellular SMAD transcription factors and their nuclear cofactors. The extent, duration and potency of signalling in response to TGFβ cytokines are intricately regulated by complex biochemical processes. The corruption of these regulatory processes results in aberrant TGFβ signalling and leads to numerous human diseases, including cancer. Reversible ubiquitylation of pathway components is a key regulatory process that plays a critical role in ensuring a balanced response to TGFβ signals. Many studies have investigated the mechanisms by which various E3 ubiquitin ligases regulate the turnover and activity of TGFβ pathway components by ubiquitylation. Moreover, recent studies have shed new light into their regulation by deubiquitylating enzymes. In this report, we provide an overview of current understanding of the regulation of TGFβ signalling by E3 ubiquitin ligases and deubiquitylases.

Keywords: DUBs; deubiquitylation; transforming growth factor; ubiquitin; ubiquitination; ubiquitylation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The logic of TGFβ signalling from the membrane to nucleus. Upon ligand binding, the TGFβ/BMP receptor kinases mediate the phosphorylation of R-SMADs. R-SMADs are depicted showing their MH1/Linker/MH2 domains. This induces the association of R-SMADs with SMAD4 and their nuclear translocation. In the nucleus, the SMADs form transcription complexes with multiple cofactors and regulate the transcription of multiple target genes. Most of the known transcriptional cofactors of SMADs are indicated, although not all are described in the text.
Figure 2.
Figure 2.
Regulation of the TGFβ–BMP receptor complexes by reversible ubiquitylation. Sketch of how reversible ubiquitylation of the receptor complexes may regulate pathway signalling. Detailed description is covered in the text.
Figure 3.
Figure 3.
Regulation of SMAD transcription factors and nuclear cofactors by reversible ubiquitylation. An overview of how reversible ubiquitylation of SMAD transcription factors and associated nuclear cofactors may impact the SMAD-dependent transcription. Most of the reported E3s and DUBs known to regulate specific proteins are included. The reported mechanisms by which different E3 ubiquitin ligases and DUBs regulate SMAD proteins and associated cofactors are described in the text.

References

    1. Massagué J, Gomis RR. 2006. The logic of TGFbeta signaling. Febs Lett. 580, 2811–2820 10.1016/j.febslet.2006.04.033 (doi:10.1016/j.febslet.2006.04.033) - DOI - PubMed
    1. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685–700 10.1016/S0092-8674(03)00432-X (doi:10.1016/S0092-8674(03)00432-X) - DOI - PubMed
    1. Moustakas A, Pardali K, Gaal A, Heldin CH. 2002. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 82, 85–91 10.1016/S0165-2478(02)00023-8 (doi:10.1016/S0165-2478(02)00023-8) - DOI - PubMed
    1. Wu MY, Hill CS. 2009. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev. Cell 16, 329–343 10.1016/j.devcel.2009.02.012 (doi:10.1016/j.devcel.2009.02.012) - DOI - PubMed
    1. Bierie B, Moses HL. 2010. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 21, 49–59 10.1016/j.cytogfr.2009.11.008 (doi:10.1016/j.cytogfr.2009.11.008) - DOI - PMC - PubMed

Publication types

MeSH terms